|
|
|
|
|
Received: 13 December 2020
|
|
|
|
|
|
[1] 丁涛,张士辉.孟鲁司特钠联合布地奈德治疗小儿咳嗽变异性哮喘的临床疗效和安全性评价[J].医学综述,2015,22(14):2637-2638.
[2] 张华. 分析孟鲁司特钠联合布地奈德治疗小儿咳嗽变异性哮喘(CVA)的效果[J].中国医药指南,2018,16(2):74.
[3] 王丽红,李亚蕊,王春岩,等.孟鲁斯特钠联合布地奈德对小儿咳嗽变异性哮喘气道重塑的影响[J].中国妇幼保健,2019,34(10):2267-2269.
[4] 王利君. 孟鲁司特钠联合布地奈德治疗57例小儿咳嗽变异性哮喘的临床疗效观察[J].现代诊断与治疗,2018,29(9):1356-1358.
[5] 田晓曦. 小儿咳嗽变异性哮喘患儿实施布地奈德联用孟鲁司特钠治疗的效果观察[J].山西医药杂志,2018,47(10):1168-1170. |
| [1] |
. [J]. journal1, 2021, 41(5): 70-71. |
| [2] |
. [J]. journal1, 2021, 41(5): 92-92. |
| [3] |
. [J]. journal1, 2021, 41(5): 101-102. |
| [4] |
. [J]. journal1, 2021, 41(5): 139-140. |
| [5] |
Zhang Dan, Zhang Xiaofei. Curative Effect of Compound Glycyrrhizin Injection in Adjuvant Treatment of Children With Henoch-Schonlein Purpura Nephritis and the Influence on Cytokines[J]. journal1, 2021, 41(4): 17-18. |
| [6] |
Liang Menglin, Huang Xiangmin, Tan Xiong. Effect of Vitamin AD on Children With Recurrent Respiratory Tract Infection[J]. journal1, 2021, 41(4): 21-23. |
|
|
|
2021, Vol. 41 
